Tarceva: Oral tablet (100mg)
Detailed Information
Also see:
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Visit Drug Summary Page
Print
Check Drug Interactions
What is this Medicine?
ERLOTINIB (er LOE ti nib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat non-small cell lung cancer and pancreatic cancer.
In-Depth Information
Tarceva 100mg Tablet
NDC: 502420063-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
FDA approved for the following conditions:
Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer
Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer
Sometimes used for but not FDA approved for the following conditions:
Head And Neck Cancer
Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Reported Side Effects for Tarceva 100mg Tablet
Decreased Appetite
Incidence:
<9.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Fainting
Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Onset: EARLY
Abnormal Heart Rhythm
Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Back Pain
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Chest Pain
Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Conjunctivitis
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Elevated Hepatic Enzymes
Incidence:
<14.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Muscle And/Or Bone Pain
Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Blood Clot
Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Blood Clot
Incidence:
<4.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Weight Loss
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Upset Stomach
Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Bowel Obstruction
Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Joint Pain
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Cough
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Depression
Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Loose Stools
Incidence:
<7.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Tired
Incidence:
<18.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Fever
Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Headache
Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Hemolytic Anemia
Incidence:
<1.4%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
High Bilirubin Level
Incidence:
<11.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Heart Attack
Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Inflamed Eye
Incidence:
<12.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Itching
Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Onset: RAPID
Mouth Ulcers
Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Low Platelet Count
Incidence:
<1.4%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Dry Skin
Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Hole In Intestines
Incidence:
0.2-0.4%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Liver Failure
Incidence:
0.4%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Stevens-Johnson Syndrome
Incidence:
0.4-1.2%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Lyell'S Syndrome
Incidence:
0.4-1.2%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Brain Attack
Incidence:
0.6-2.5%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Lung Inflammation
Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Onset: DELAYED
Infection
Incidence:
4.0-16.0%*
Severity: SEVERE
Onset: DELAYED
Onset: DELAYED
Skin Rash
Incidence:
5.0-14.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Shortness Of Breath
Incidence:
8.0-28.0%*
Severity: SEVERE
Onset: EARLY
Onset: EARLY
Weakness
Incidence:
>30.0%*
Severity: MILD
Onset: DELAYED
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Tarceva 100mg Tablet
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.
Major Lifestyle Interaction
Grapefruit juice and Tarceva 100mg Tablet(Erlotinib)
Grapefruit juice and Erlotinib(Erlotinib)
Avoid Grapefruit or Grapefruit juice while receiving Erlotinib treatment. Side effects from Erlotinib may get worse if you take Grapefruit Juice. Contact your health care provider if you experience rash, diarrhea, fatigue, breathing problems, nausea, vomiting, or other unusual effects.
Major Lifestyle Interaction
Tobacco and Tarceva 100mg Tablet(Erlotinib)
Tobacco and Erlotinib(Erlotinib)
Do not smoke while taking Erlotinib. Talk to your health care professiona if you are a smoker. Smoking may decrease erlotinib levels, causing your cancer therapy to not work as well for you. If you have been smoking and then stop smoking, you may need careful monitoring, Inform your prescriber of any change in smoking status. If you stop smoking, erlotinib levels can increase or you may experience side effects. An erlotinib dose adjustment may be necessary in some patients who smoke or who quit smoking; do not adjust the dose by yourself.
Pregnancy & Lactation Information
First Trimester
Class 3 - Risk Documented in Animals
Second Trimester
Class 3 - Risk Documented in Animals
Third Trimester
Class 3 - Risk Documented in Animals
Lactation
Avoid - This drug is known to cause harm to infants when taken by nursing mothers.
Learning More About
Visit the Drug Summary page where you can:
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Patient Experiences with Tarceva
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.
Average Scores
Easy to Take
0
/
5
Works as Intended
0
/
5
Tolerable
0
/
5
